Oxazolidinone amide aromatic compounds for supressing MMP-9 production
US8354401B2 · kind B2 · utility
8Cited by
0References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 27, 2009 |
| Grant date | Jan 15, 2013 |
| Priority date | — |
| Expiry date | Oct 27, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are a novel low-molecular-weight compound that suppresses production of induction type MMPs, particularly MMP-9, rather than production of hemostatic type MMP-2, as well as a prophylactic/therapeutic drug for autoimmune diseases or osteoarthritis. An amide derivative represented by the following formula (I)wherein each symbol is as defined in the specification, a pharmacologically acceptable salt thereof, or a hydrate or solvate thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.